APA (7th ed.) Citation

C, F., & T, T. (2026). Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis. American journal of clinical dermatology, 27(3), 479. https://doi.org/10.1007/s40257-026-01019-0

Chicago Style (17th ed.) Citation

C, Ferreira, and Torres T. "Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis." American Journal of Clinical Dermatology 27, no. 3 (2026): 479. https://doi.org/10.1007/s40257-026-01019-0.

MLA (9th ed.) Citation

C, Ferreira, and Torres T. "Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis." American Journal of Clinical Dermatology, vol. 27, no. 3, 2026, p. 479, https://doi.org/10.1007/s40257-026-01019-0.